Meta-analysis of 18 ivermectin studies reports benefit
Simon Collins, HIV i-Base
A new meta analysis on the controversial question of whether ivermectin has a beneficial role in management of COVID-19 this time reports in it’s favour. 
This is in contrast to a recent randomised study reported in HTB that found no benefit in mild infection. 
Other large randomised studies are ongoing but likely to report soon.
- Kory P et al. Review of the emerging evidence demonstrating the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. American Journal of Therapeutics. 2(3):e299-e318 doi: 10.1097/MJT.0000000000001377. (May/June 2021),
- Ivermectin has no impact in treating mild COVID-19 in 400 adults in Columbia. HTB (12 March 2021).